General Information

Stock Quote

ABMD (Common Stock)
Exchange NASDAQ (US Dollar)
Price   $25.60
Change (%)   Stock is Down  1.14  (4.26%)
Volume   714,600
Data as of 07/31/14 4:00 PM ET
Minimum 20 minute delay
Refresh quote

Corporate Profile

Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES.

Abiomed CEO, Chairman, and President, Michael R. Minogue, has focused the company’s efforts on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart. The Company’s portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world’s first total replacement heart to the World’s Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.

More>>

More »   Recent News

Date Title  
07/31/14

DANVERS, Mass., July 31, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2015 revenue of $48.8 million, an increase of 14% compared to revenue of $42.7 million for the same period of fiscal 2014. First quarter fiscal 2015 GAAP net loss was $1.7 ...

07/01/14

DANVERS, Mass., July 1, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (ABMD), a leading provider of breakthrough heart sup...

06/04/14

DANVERS, Mass., June 4, 2014 (GLOBE NEWSWIRE) -- The MedTech and BioTech Veterans Program (MVP) announced today it will host the Boston area's first-ever Student Veteran Re-careering Seminar for alumni and student military veterans interested in pursuing careers in the life sciences. MVP is a newly-expanded nationwide initiative designed to pro...

06/04/14

DANVERS, Mass., June 4, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the William Blair Growth Stock Conference on June 11, 2014 at 10:40 a.m. CDT. The conference will be he...

06/03/14

DANVERS, Mass., June 3, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported that physicians have implanted more than 20,000 Impella® pumps in U.S. patients requiring hemodynamic support. The 20,000th Impella procedure took place at Keck Medicine of University of So...